LOW-DOSE NALTREXONE SHOWS PROMISE

Researchers at Stanford University report that a study of 31 women with fibromy algia (FM) shows promising results for low-dose naltrexone to reduce pain and improve mood and satisfaction with life. The study used a cross-over design and participants received medication for 12 weeks and placebo for four weeks with a four-week follow-up period. Abstract from […]

Read More

Manual Therapy in CFS: Part 1 of 2

By Peter C. Rowe, MD, Kevin R. Fontaine, PhD and Rick L. Violand, PT Mark Twain loathed exercise. “Whenever I get the urge to exercise,” he is said to have remarked, “I lie down until it goes away.” He did acknowledge that his approach was not right for everyone. Beyond the intended humor of his […]

Read More

Introducing Leigh Reynolds: Our Newest Team Member

This is an exciting post to write! I am so thrilled to be joining the Solve ME/CFS Initiative as the new engagement manager. But let me begin at the beginning… My name is Leigh Reynolds and I come to the Solve ME/CFS Initiative as my next step in serving the nonprofit community. For two decades […]

Read More

CDC Stakeholder Call Coming Up

In the fall of 2012, the U.S. Centers for Disease Control and Prevention (CDC) began a new series of conference calls to update stakeholders about CFS-related research activities and other topics of interest. Information on the next call, scheduled for Jan. 14, 2013, is provided below from their listserv and website. To sign up for […]

Read More